<DOC>
	<DOCNO>NCT02338011</DOCNO>
	<brief_summary>1 . Compare effect safety gefitinib alone gefitinib plus concomitant WBRT ( whole-brain radiotherapy ) treatment NSCLC patient harbor EGFR mutation multiple BM . 2 . Verify failure pattern NSCLC patient harbor EGFR mutation multiple BM . 3 . Explore rescuable therapy progression disease .</brief_summary>
	<brief_title>Comparator-Controlled Study EGFR ( + ) Patients With Multiple BMs From NSCLC ( BROKE ) ( EGFR-epidermal Growth Factor Receptor ; BM-brain Metastases )</brief_title>
	<detailed_description>All patient randomize receive gefitinib gefitinib concurrent WBRT progression disease . Gefitinib concurrent WBRT , patient give gefitinib 250mg per day concurrently WBRT ( whole-brain radiotherapy ) . Dose reduction allow intolerable adverse effect rash ( grade 4 ) 、diarrhea ( grade 3-4 ) non hematological toxicity ( grade 3-4 ) 250mg per day 250mg every day 250mg every three day need . WBRT deliver 3.0 Gy ( Gray ) fraction per day 5 day per week total dose 30Gy ( 10 fraction ) . Radiation deliver opposed lateral 6-MV ( Micro Voltage ) beam Varian linear accelerator .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<criteria>year age old ECOG score ≤ 2 Recursive Partitioning Analysis ( RPA ) Class III ; The pathological diagnosis primary nonsmall cell lung cancer detection pulmonary primary ARMs ; Sequencing EGFR mutation ( primary lesion metastasis , exon 19 deletion exon 21 L858R ( EGFR mutation exon 21 , L858R point mutation ) mutation ; Enhanced MRI show brain metastasis ≥ 4 ; 1 2 line treatment reveal failure ; No use EGFRTKIs ( Tyrosine kinase inhibitor ) previously； No treatment BM previously , include WBRT、SRS、surgery experimental therapy ; Expected survival period 3 month ; Two week randomization , organ function patient meet follow criterion : bone marrow : HB ( hemoglobin ) ≥ 90g/L , neutrophil≥ 1.5 × 109/L platelet ≥ 100 × 109/L ; liver function : total bilirubin ≤ 1.5 time upper limit normal , aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) ≤ 3 time upper limit normal ; renal function : 1.5 time upper limit normal serum creatinine creatinine clearance rate ≥ 60 ml/min ; Urine dipstick test proteinuria &lt; 1+ ; urine dipstick test value , 1+ , 24 hour total urine protein must &lt; 500mg ; blood glucose : normal range , DM ( diabetes mellitus ) patient treatment stable state ; Can understand consent Patients treat brain radiation surgery BM ; Prior EGFRTKIs； Mixed small cell lung cancer patient component ; Wildtype EGFR ; Unable tolerate MRI scanning ; Post 2 line treat patient ; Brain meninges metastasis incorporate brain meninges metastasis ; 5 year cancer except NSCLC treatment patient start study ( except simple operation resection least 5 consecutive year disease free survival , cure cervical carcinoma situ , cure base cell cancer bladder epithelial tumor ) ; Before enter group 4 week receive investigational drug ; Incorporate local symptoms（hemiplegic paralysis、anepia、nystagmus、ataxia.et ) ; Pregnancy lactation female ; Allergic EGFRTKIs component ; Patients permit receive follow drug : phenytoin , carbamazepine , rifampicin , phenobarbital itraconazole potential affect metabolism EGFRTKIs reduce plasma concentration . Patients permit receive oral medicine CoumadinTM、Warfarin . If anticoagulant therapy need , low molecular heparin suggest instead Coumarin drug ; Organs function patient meet follow criterion : Diagnose interstitial lung disease、drug induce interstitial disease、hormone dependent radiation pneumonia previously , et al ; Any unstable system disease : include active infection , moderate severe chronic obstructive pulmonary disease , uncontrolled hypertension , unstable angina pectoris , congestive heart failure , within last 6 month onset myocardial infarction , need serious mental disorder drug treatment , liver , kidney metabolic disease ; mental / spiritual diseases Alzheimer 's disease ; Gastrointestinal tract disease result inability take oral medication requirement intravenous ( IV ) alimentation , prior surgical procedure affect absorption active peptic ulcer ; With immunodeficiency disease , suffer acquire , congenital immunodeficiency disease , history organ transplantation ; Known human immunodeficiency virus ( HIV ) infection ; Without full control ocular inflammation eye infection , may cause eye disease situation ; Any disease , metabolic disorder , physical examination laboratory suspicion treatment complication patient high risk drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>